Topic: Food and Drug Administration
If you have suffered from snoring or a similar sleep condition for some time, you have most likely become aware of the plethora of anti snore aids that are available for purchase. Some are not so good, but the majority offer great ...
WASHINGTON (Reuters) - Tylenol PM and other widely used acetaminophen pain drugs that include a sleep-aid failed to show significant benefit in a key study, U.S. health regulators have told drugmakers 15 years after the industry submitted the data. Patients taking the ...
Somaxon to sell 4 million shares to raise funds for marketing insomnia drug SilenorJust days after receiving Food and Drug Administration approval for Silenor, biotech company Somaxon Pharmaceuticals Inc. made plans to sell 4 million shares to fund marketing of the insomnia ...
Cephalon says FDA decision on Nuvigil as treatment for jet lag is now due March 29The Food and Drug Administration needs more time to review Cephalon Inc.'s drug Nuvigil as a treatment for jet lag, Cephalon said Monday.Cephalon is seeking approval to ...
Are you looking for reviews of Stop Snoring mouth device like mouth guards? There is a wide range of products and exercise programs today that can help get rid of a person's snoring, and mouth devices are one of them. Some people ...
BOSTON (Reuters) - Drug labels in the United States often omit information showing the severity of side effects or that a medicine is not very effective, two doctors said Wednesday.The result can be a document skewed toward making a medicine seem safer ...
Transcept surges after company enters US sleep aid promotion agreement with Purdue PharmaShares of Transcept Pharmaceuticals Inc. rocketed Monday after the company said it licensed its insomnia treatment candidate Intermezzo to Purdue Pharmaceutical Products LP for up to $145 million, plus royalty ...
Eating a little bit of chocolate was a treat that Teresa Wood looked forward to after work. "Complex behaviors, such as sleep-driving, could be potentially dangerous to both the patients and to others," says Russell Katz, M.D., Director of the Food and ...
A pharmaceutical company admitted Friday in a settlement that it marketed a powerful depressant to doctors for illnesses it was not approved to treat. Orphan Medical Inc., a subsidiary of Jazz Pharmaceuticals Inc., pleaded guilty in U.S. District Court in Brooklyn to ...